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ionization mass spectrometry; GST, glutathione S-transferase; HPLC, high-performance        
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Abstract 
 
The yeast ​Pichia pastoris is a cost-effective and easily scalable system for recombinant             
protein production. In this work we compared the conformation of the receptor            
binding domain (RBD) from SARS-CoV-2 Spike protein expressed in ​P. pastoris and in             
the well established HEK-293T mammalian cell system. RBD obtained from both yeast            
and mammalian cells was properly folded, as indicated by UV-absorption, circular           
dichroism and tryptophan fluorescence. They also had similar stability, as indicated by            
temperature-induced unfolding (observed ​T​m were 50 °C and 52 °C for RBD produced in              
P. pastoris and HEK-293T cells, respectively). Moreover, the stability of both variants            
was similarly reduced when the ionic strength was increased, in agreement with a             
computational analysis predicting that a set of ionic interactions may stabilize RBD            
structure. Further characterization by HPLC, size-exclusion chromatography and mass         
spectrometry revealed a higher heterogeneity of RBD expressed in ​P. pastoris relative            
to that produced in HEK-293T cells, which disappeared after enzymatic removal of            
glycans. The production of RBD in ​P. pastoris was scaled-up in a bioreactor, with yields               
above 45 mg/L of 90% pure protein, thus potentially allowing large scale immunizations             
to produce neutralizing antibodies, as well as the large scale production of serological             





The COVID-19 outbreak was first recognized in December 2019 in Wuhan,           
China ​1​. Since then, this virus has spread to all parts of the world, resulting in a total of                  
29415168 infected individuals and 931934 deaths by September 14​th ​, 2020          
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( ​https://www.coronatracker.com ​). The causative agent is a coronavirus that causes a          
severe acute respiratory syndrome (SARS). This SARS-related coronavirus (SARSr-CoV)         
has been designated as SARS-CoV-2. 
Coronaviruses are enveloped non-segmented positive sense RNA viruses​2 that         
have four open reading frames (ORFs) for structural proteins -Spike, Envelope,           
Membrane, and Nucleocapsid- ​3,4​, from which Spike is the primary determinant of CoVs            
tropism. Spike mediates the viral and cellular membrane fusion by binding mainly to             
the angiotensin-converting enzyme 2 (ACE2), a homologue of ACE ​5,6​.  
The SARS-CoV-2 genome has 29903 nucleotides in length ​7​, sharing 79% and            
50% sequence identity with SARS-CoV-1 and MERS-CoV genomes, respectively​8​.         
Genetic studies suggest that both viruses originated from bat CoVs​8,9​, with civet cats as              
intermediate hosts in the case of SARS-CoV-1​10​, and pangolins in the case of             
SARS-CoV-2 ​11,12​. Among the structural proteins, the Envelope protein has the highest           
sequence similarity between SARS-CoV-2 and SARS-CoV-1 (96% identity), while the          
Spike protein, responsible for the interaction with the host receptor, the largest            
sequence divergence (76% identity with SARS-CoV-1) ​13​. It has been suggested that the            
divergence of Spike could be related to an increased immune pressure​1​. Consistently            
with the proposed role of pangolins as SARS-CoV-2 intermediate hosts, CoVs from            
pangolins share the highest genetic similarity with this virus in the region encoding the              
receptor binding domain (RBD) of the Spike protein​11,14​. 
Due to its important role for SARS-CoV-2 entry into the host cell, Spike is the               
most studied protein of this virus. This transmembrane glycosylated protein is           
composed of 1273 amino acid assemblies as a homotrimer that forms spikes that             
protrude from the virus envelope. Spike has two domains, named S1 and S2 . Residues               
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319-591 from S1 correspond to the RBD, responsible for the interaction with ACE2​15​.             
RBD binds with high affinity to the ACE2, located on the outer surface of the cell                
membrane, which acts as a SARS-CoV-2 receptor since it mediates the fusion of the              
virus to the cell membrane​16​. Spike also includes a transmembrane domain and a fusion              
peptide​17​. 
Molecular dynamics simulations suggest that internal motions of the Spike          
trimer are important to expose the RBD domain so it can interact with the target               
receptor. However, part of the time RBD domain is hidden within the rest of the Spike                
protein, and this process is mediated by protein motions of high amplitude. The             
structure of RBD-ACE2 protein complex and the structure of Spike (as the full-length             
and trimeric form of the protein) were determined by X-ray crystallography and            
cryo-EM​16,18–20​.  
RBD is a protein domain of 220 residues, it has nine cysteine residues (eight of               
them forming disulfide bonds) ( ​Figure 1​) and two ​N-​glycosylation sites (N331 and            
N343). The addition of glycan moieties might have a relevant role on the ​in vivo protein                
folding process, on the dynamics, stability and solvent accessibility of RBD and also on              
its immunogenicity​21,22​. RBD is not a globular protein domain; it has a central twisted              
antiparallel beta-sheet formed by five strands decorated with secondary structure          
elements (short helices and strands) and loops​19​. The secondary structure analysis of            
the protein shows 12.4% helix, 33.0% sheet, 19.1% turn, and 35.6% coil. 
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Figure 1. Structure of Sars-Cov-2 Receptor Binding Domain bound to ACE2. ​The            
secondary structure elements of RBD are differentially colored (Alpha helices: purple,           
3_10 helices: iceblue, beta strands: yellow, and turns/coil: cyan). Disulfide bridges (red)            
and tryptophan residues (blue) are shown as sticks, while N-glycosylation asparagine           
residues (green) are shown as VDW spheres. The region of ACE2 encompassing            
residues 1-115 (colored white) which interacts with RBD is also shown. The structure             
was generated using PDB structures 6xm0 and 6m0j.  
 
Despite its medium size of 25 kDa, RBD is an example of a challenging protein               
domain to express in heterologous systems due to its complex topology (Figure 1).             
Nevertheless, it is of high importance to produce and purify RBD at low-cost and              
efficiently, since this domain is extensively used for the development of serological test             
kits as well as an immunogen, both for the production of animal immune sera and for                
vaccine development ​23​. While ​E. coli is a cost-efficient system for the expression of             
many proteins, it is unlikely to be the case for RBD due to its requirement of disulfide                 
bond formation and glycosylation for its proper expression and folding. For this reason,             
RBD is usually expressed in mammalian as well as insect cells​24​, ​18​.  
The methylotrophic yeast ​Pichia pastoris is an alternative cost-effective         
eukaryotic system that allows relatively easy scaling-up of recombinant protein          
production, and which has previously been used for the expression of SARS-CoV-1 RBD             
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to produce a vaccine​25​. This yeast can use methanol as an exclusive carbon source. This               
molecule is also an inductor of the strong and tightly regulated AOX1 promoter​26​,             
which can therefore be used to drive recombinant protein expression. When cultured            
in bioreactors, ​P. pastoris can reach high cell densities, and more importantly, this             
organism allows the efficient secretion of recombinant proteins to the culture medium,            
which contains relatively low levels of endogenous proteins, thus allowing the           
straightforward purification of recombinant secretory proteins​26​.  
In this work we expressed and purified SARS-CoV-2 Spike RBD from two            
different systems -the yeast ​P. pastoris and mammalian cells- and compared their            
structure, stability, glycosylation status, and immunogenicity in mice. Our work          
provides useful insights on the production of a key protein used in diagnosis and              
therapeutics to fight COVID-19 pandemia. 
 
Results  
SARS-CoV-2 RBD Protein Sequence analysis 
Prior to designing the constructs to express Spike RBD domain from SARS-CoV-2            
we looked for possible variation in its coding sequence in genomes publicly available at              
the Global Initiative for Sharing All Influenza Data (GISAID) database          
( ​https://www.gisaid.org ​) ​27​. From a total of 75355 SARS-CoV-2 genome sequences available          
at GISAID, 85.8% (64,707 genomes) have 100% coverage of RBD (non truncated Spike             
proteins) with 100% of amino acid identity to the first published RBD sequence             
(Uniprot: ​QHN73795.1 ​) ​28​. This data set includes 38 Argentinean SARS-CoV-2 genomes.          
RBD sequences from the remaining genomes (14.2%) were distributed as follows: 3.5 %             
(6199/64707) have more than 99% of amino acid sequence identity (up to 2 amino acid               
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substitutions or InDels), 1.4% (925/64707) have more than 80% (up to 44 amino acid              
substitutions or InDels) and only 300 genomes have a lower amino acid identity relative              
to the first published sequence. Thus, we considered appropriate to express the            
predominant RBD form, spanning from residue 319 to 537 of Spike protein, which             
consists of a relatively compact domain, and includes a slightly disordered C-terminal            
stretch useful for protein engineering (​Figure 1​).  
 
Expression of RBD in mammalian and yeast cells 
The expression of RBD in mammalian cells (HEK-293T cell line) and in ​P. pastoris              
yielded significant quantities of protein (∼5 and 10-13 mg L ​-1 of cell culture,             
respectively, at a laboratory scale). In both cases, the recombinant protein was fused to              
appropriate secretion signal peptides, IL2 export signal peptide for HEK-293T          
expression and ​Saccharomyces cerevisiae α-factor secretion signal for ​P. pastoris          
expression. Both secretion signals allowed the recovery of mature RBD from cell            
culture supernatants.  
Since RBD expressed in both eukaryotic systems included a C- terminal His tag,             
similar purification protocols were used in both cases. However, given that the            
physico-chemical conditions required for optimal growth of mammalian and yeast cells           
were completely different (HEK-293T cells were grown at 37 ​o​C in a medium buffered              
to pH 7.4, while ​P. pastoris were grown at 28 ​o​C, buffered to pH 6.0), the covalent                 
structure, intactness, conformation, post translational modifications and stability of         
RBD might still differ depending on the expression system used. Additionally, both            
strategies involved the accumulation of soluble RBD in the supernatant, which can pose             
an extra challenge for unstable proteins. For these reasons, it was crucial to evaluate              
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parameters such as protein aggregation, oxidation, and possible alterations in disulfide           
bond patterns of proteins obtained from the different media.  
NTA-Ni​2+​-purified RBD from both HEK-293T and yeast exhibited high purity          
(>90%), as judged by SDS-PAGE analysis ( ​Figure 2A​). RBD from HEK-293T cells migrated             
as a 35 KDa single-smear band in SDS-PAGE 12%, while RBD produced in ​P. pastoris               
migrated as one highly diffuse and more abundant band of ∼45-40 kDa, and a less               
abundant band of ∼35 kDa, the latter similar to that of RBD produced in HEK-293T cells.  
HPLC profile analysis revealed that RBD produced in HEK-293T cells is highly            
homogeneous, as shown by its elution as a sharp peak at 48-49 % of acetonitrile in a                 
reverse phase C18 column, while RBD produced in ​P. pastoris showed a considerably             
broader peak, although it eluted at very similar acetonitrile concentration. In addition,            
two very small peaks appeared in the chromatogram of RBD produced in ​P. pastoris​.              
The area corresponding to the full-length protein was approximately 87%.  
The SDS-PAGE analysis of RBD purified from yeast and mammalian cell culture            
supernatants suggested the existence of glycosylation as the main post-traslational          
modification in RBD, as its theoretical mass (deduced from the amino acid sequence) is              
∼26 kDa ( ​Figure 2 ​), while both recombinant RBD forms migrated as products of more              
than 32-35 kDa. This was expected, since two ​N​-glycosylation consensus sequences           
(NIT and NAT) are present at RBD N-terminal region. RBD from SARS-CoV-1 also bears              
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Figure 2. Analysis by SDS-PAGE and RP-HPLC of RBD produced in ​P. pastoris or              
HEK-293T, and purified by NTA-Ni ​2+​. ​Analysis of recombinant RBD fractions eluted           
from a NTA-Ni​2+ ​column by 300 mM imidazole after purification from supernatants of a              
P. pastoris culture (A) or of HEK-293T cells (B). (C) Reverse Phase HPLC Analysis of RBD.                
Profiles for RBD produced in ​P. pastoris (red) and HEK-293T mammalian cells (black).             
The inset shows the expanded region of the chromatogram where the highest peaks             
eluted. The dashed blue line indicates the variation of acetonitrile (% v/v) during the              
experiments. Peaks 1, 2 and 3 from RBD produced in ​P. pastoris correspond to areas of                
10.1, 2.8 and 87.1%, respectively. 
 
Even though Coomassie Blue staining showed heterogeneity in protein size,          
incubation with PNGaseF, a peptide-endoglycanase that removes high mannose,         
complex and hybrid N-glycans from proteins, homogenized all isoforms to a sharper            
11 
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band of ∼25-26 kDa, compatible with the predicted MW of deglycosylated RBD (26.5             
kDa, ​Figure 3​). The decrease in the molecular mass of RBD by endoglycanase digestion              
confirmed the existence of ​N​-glycosylations in both proteins. Moreover, glycans from           
P. pastoris-​RBD - and not from HEK-293T-RBD - were also removed by EndoH, an              
endoglycanase that eliminates only high-mannose type glycans, which are the expected           
type in ​P. pastoris yeasts. These results strongly suggest that RBD from mammalian             
cells bears only complex or hybrid glycans, while RBD from ​P. pastoris only bears high               
mannose glycans. Moreover, the persistence of two bands in RBD from HEK-293T cells             
after exhaustive deglycosylation with PNGaseF suggests the existence of         
heterogeneous ​O ​-glycosylation, although heterogeneity in amino acid sequence cannot         
be discarded either. 
The identity of the RBD forms was corroborated by fragmentation, controlled           
proteolysis, peptide assignment and MS/MS sequencing (MALDI TOF TOF for tryptic           
peptides analysis). ​Figure 4 shows molecular masses and spectra from the intact mass             
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Figure 3. Analysis of the glycosylation status of RBD produced in HEK-293T and ​P.              
pastoris ​. ​(A) Schematic representation of SARS-CoV-2 S glycoprotein. N-terminal         
domain (NTD), receptor-binding domain (RBD), furin cleavage site (S1/S2), central helix           
(CH), connector domain (CD), and transmembrane domain (TM) are displayed.          
Residues involved in RBD glycosylation are shown ( ​O​- and ​N​-glycosylations are           
indicated by dotted and solid lines, respectively). (B) Endoglycanase treatment of RBD.            
Purified RBD (3 ug) from mammalian or yeast culture supernatants was denatured 10             
min at 100 °C and digested with PNGase F (500 mU) or EndoH (5 mU) during 2 h at 37                    
°C. Proteins were separated in a 14% SDS-PAGE gel. The positions of non-glycosylated             
and glycosylated RBD isoforms are indicated. The bands corresponding to PNGaseF (36            
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Figure 4. MALDI TOF Spectra for RBD Samples. ​(A) RBD prepared in HEK-293T and (B) 
RBD prepared in ​P. pastoris​. As expected, the glycosylated species from ​P. pastor ​is 
have a broad mass.  
 
The peptide spectrum matches – PSM – with significant score from the MS/MS             
analysis clearly showed that protein species present in the samples belonged to the             
RBD from SARS-CoV-2, ( ​Table 2​). The masses of peptides identified by MS/MS or             
peptide mass fingerprint ( ​Table 2​) were in good agreement with those expected from a              
proteotypic peptide prediction software -PeptideRank ​29​, and from the information         
available from the Peptide Atlas database ​30 for peptides identified from SARS-CoV-2. To            
further validate the PSM findings, the data was also analyzed with COMET at             
Transproteomic Pipeline (a different MS/MS search engine), which produced similar          
results ​31,32​. 
As expected due to the dispersion in sizes, the ​FPNITNLCPFGEVFNATR peptide that            
harbors two glycosylation consensus sequences –NIT and NAT motifs– was not           
observed in the RBD samples from ​P. pastoris ​or HEK-293T cells. On the other hand, a                
deglycosylation of RBD produced in ​P. pastoris​, followed by MS/MS analysis revealed a             
14 
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m/z signal only present in that sample, in which two HexNAc moieties identified at the               
two N residues in FPNITNLCPFGEVFNATR ( ​Figure S1​). 
 
Table 2. MS/MS Analysis Results for In-solution Digestion of RBD obtained from            
HEK-293T and from P. pastoris​. Protein coverage was of ∼40 and ∼60%, for RBD               
produced in ​P. pastoris and ​HEK-293T cells, respectively. The experimentally obtained           
(MW (expt)) and the calculated (MW (calc)) molecular weights of the peptides, and             
their difference (ppM) are shown. The protein sequence of each construct is shown,             
red letters indicate the peptides identified either by MS/MS analysis or peptide mass             
fingerprint (less than 60 ppm error). 
 
Conformational characterization of RBD forms by UV absorption 
Different analytical techniques were used to characterize proteins produced in          
yeast or mammalian cells. The UV absorption spectra of both recombinant proteins            
were very similar; they are dominated by a high content of tyrosine residues (16 Tyr, 2                
Trp, 15 Phe, 4 disulfide bonds), as indicated by bands at approximately 276.0 and 281.0               
15 
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nm. The absence of light scattering -suggested by the absence of a typical slope              
between 340 and 300 nm- strongly indicated that the proteins do not form soluble              
aggregates ( ​Figure 5 ​). However, freezing and thawing resulted in protein precipitation           
when RBD concentration was higher than 80 μM (data not shown).  
The fourth derivative of absorption spectra can be used to evaluate RBD native             
conformation. Spectra corresponding to RBD produced in HEK-293T cells and ​P.           
pastoris were superimposable ( ​Figures 6B and C ​), suggesting a similar packing of the             
aromatic residues. In particular, the positive band at 290.4 nm corresponding to Trp             
residues observed in the native state of RBD ( ​Figure 6C​) showed a significant red shift               
compared to the 288 nm band of N-acetyl-L-tryptophanamide (NATA), suggesting that           
Trp residues in RBD are not fully exposed to the solvent ( ​Figure 6B​). Also the negative                
band at 287.8 nm (a contribution of Tyr and Trp residues) showed a significant red shift                
compared to that observed for the fully exposed NATA and N-acetyl-L-tyrosinamide,           
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Figure 5. Absorption Spectroscopy. (A) Spectra corresponding to purified RBD produced in            
HEK-293T cells (black), ​P. pastoris (clones 1 (blue) and 7 (red), and a simulated RBD spectrum                
(green) (27.5 μM) calculated from its composition of aromatic amino acid (15 Phe, 15 Tyr and                
2 Trp in RBD). (B) Fourth derivative spectra corresponding to the aromatic amino acids (Tyr               
(blue), Trp (violet), Phe (yellow)) and a simulated RBD spectrum (green). (C) Comparison             
between the fourth derivative spectra from RBD obtained in HEK-293T (black), ​P. pastoris             
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Hydrodynamic behavior of RBD forms analyzed by SEC-HPLC 
 
SEC-HPLC experiments of RBD produced in ​P. pastoris confirmed the absence of            
aggregated forms and showed a peak compatible with two species between 45-25 kDa             
( ​Figure 6​). Deconvolution of the chromatogram in two components by fitting to two             
gaussian curve suggested that ∼60% of the signal comes from a higher molecular             
weight component (>40 kDa), whereas the rest of the signal ∼40% corresponds to a              
lower molecular weight component (<30 kDa). It is worth mentioning that the            
exclusion profile corresponding to RBD produced in HEK-293T cells superimposes with           
the latter, suggesting a more homogeneous glycosylation of the protein. 
 
 
Figure 6. ​Hydrodynamic Behavior of RBD. (A) SEC-HPLC of RBD produced in P. pastoris              
(red), HEK-293T (black) and molecular weight markers (dashed green line). This           
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analysis was carried out by injecting 50 μL protein aliquots (0.70 and 0.75 mg/mL for               
RBD produced in ​P. pastoris and HEK-293T, respectively) in 20 mM Tris-HCl, 100 mM              
NaCl, pH 7.0 buffer. The inset shows the correlation between molecular weight and             
elution volume obtained from the molecular weight markers: (1) gammaglobulin (158           
kDa), (2) ovoalbumin (44 kDa), (3) myoglobin (17 kDa), and (4) vitamin B12 (1350 Da).               
(B) Deconvolution analysis of the chromatographic profile from RBD from ​P. pastoris​.            
The experimental profile ​(red), deconvolution of the peak in two different gaussian            
curves (green and yellow) and the sum of the deconvoluted peaks (blue) are             
compared. 
 
Conformational characterization of RBD forms analyzed by ​circular dichroism​,         
fluorescence and thermal-induced unfolding 
RBD produced in mammalian and ​P. pastoris cells showed superimposable          
far-UV circular dichroism (CD) spectra ( ​Figure 7A​), suggesting a similar secondary           
structure. Moreover, the CD spectra are identical to that observed for RBD from             
SARS-CoV-1 produced in yeast​25​. However, given the particular shapes of the ​P. pastoris             
and HEK-293T SARS-CoV-2 RBD far-UV CD spectra (which show a single minimum at             
206 nm and a maximum at 230 nm, the latter suggesting the contribution of aromatic               
residues to the spectra), it is difficult to estimate the secondary structure content by              
using standard sets of spectra.  
We further studied the conformation of RBD produced in HEK-293T cells or P.             
pastoris by tryptophan fluorescence spectroscopy. Spectra corresponding to the native          
forms of RBD superimposed very well, suggesting that these aromatic residues are            
located in similar, apolar environments, as inferred by the maximal emission           
wavelengths observed (337 nm) ( ​Figure 8B ​). The addition of 4.0 M GdmCl resulted in a               
red shift to 353-354 nm, a result compatible with the exposure of the aromatic side               
chains to the solvent, and the total unfolding of the protein forms. Interestingly,             
unfolding of RBD produced in ​P. pastoris showed reversibility when 4.0 M GdmCl was              
diluted to 0.7 or 1.0 M, as judged by the blue shift from 353 to 337 nm and form 353 to                     
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342 nm, respectively. No reducing agents ( ​e.g. DTT, 2-mercaptoethanol) were added to            
the protein sample, indicating that the dimension of the conformational space           
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Figure 7​. ​Conformation and stability of Different Purified RBD Forms characterized by            
Circular Dichroism Spectroscopy, Tryptophan Fluorescence and Temperature-induced       
Denaturation. (A) Far-UV CD spectra of RBD produced in HEK-293T cells (black), and             
two different preparations of RBD produced in ​P. pastoris (red and blue). (B)             
Tryptophan fluorescence emission was monitored by excitation at 295 nm in 20 mM             
Tris-HCl, 100 mM NaCl, pH7.0 at 25 °C. The spectra of RBD obtained in HEK-293T (black)                
and in ​P. pastoris ​(red) ​are shown, in native conditions (solid line) and in the presence                
of 4.0 M GdmCl (dashed line) after a 3h incubation. Refolding of RBD produced in ​P.                
pastoris ​was performed by dilution to final concentrations of 0.7 M (red dot line) and               
1.0 M (red dash-dot line) GdmCl. (C) Stability analysis of RBD. Temperature-induced            
denaturation of RBD produced in ​P. pastoris (red) and HEK-293T cells (black) under             




The conformational stability of different RBD forms was studied through          
temperature unfolding experiments. Unfolding was monitored by fluorescence of         
Sypro-orange, an extrinsic probe that preferentially binds to proteins when they are in             
unfolded conformations. In these experiments, the observed ​T​m usually correlates with           
T ​m obtained from differential scanning calorimetry experiments​33​. RBD produced in ​P.           
pastoris consistently showed a slightly lower ​T​m value relative to that of RBD from              
HEK-293T cells (in all assessed conditions), an observation compatible with a reduced            
resistance to temperature-induced denaturation, which likely reflects a marginally         
lower conformational stability of RBD produced in ​P. pastoris ( ​Figure 7C​). When the             
unfolding process was studied at different ionic strengths, a significant increase in ​T​m             
was observed when NaCl concentration was reduced from 500 to 75 mM ( ​Figure 7C​),              
suggesting that the tertiary structure of RBD is stabilized by ionic pair interactions.  
 
Computational analysis of RBD structure 
The dependence of the observed ​T ​m on the NaCl concentrations, led us to             
hypothesize that increasing the ionic strength destabilizes RBD conformation by          
shielding key charged residues. Although the RBD structure suggests some energetic           
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frustration, given that there are several clusters of positively charged residues on RBD             
surface ((1) R136, R139 and K140; (2) K126, R28, R191; (3) R37, K38, R39 and R148; (4)                 
R85, R90 and K99) ​19​, our results suggest that these repulsive interactions are most             
likely compensated even in the context of the isolated RBD domain ( ​i.e. ​without the              
rest of Spike or the ACE2 receptor). This would explain why increasing ionic strength              
has a major destabilizing effect.  
The RBD crystallographic structure analysis indicates that residues have a          
particular distribution according to their type. The core subdomain (residues 333-442           
and 504-526 on the Spike protein) is enriched in non-polar residues, whereas the             
receptor-binding motif (RBM) subdomain (residues 443-503) is enriched in polar ones.           
On the other hand, the charged residues are preferentially located close to the             
interface between the Core and RBM subdomains and form an electrostatic network            
( ​Figure 8​). 
 
Figure 8. ​Subdomains and distribution of residue types on RBD ​. The Core (gray) and              
the RBM (green) regions are shown. Panels A, B, and C, shows the non-polar residues               
(orange: A, C, G, I, L, M, F, P, W and V), polar (violet: N, Q, S, T and Y), and charged                      
residues (blue: basic K, R and H, red: acid D and E), respectively. To build the models we                  
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Among the 14 positively and negatively charged residue pairs interacting at a distance             
lower than 6 Å, 8 are in the core subdomain, 5 in the RBM, and 1 pair is between the                    
Core and RBM subdomains ( ​Table 3​). The existence of 6 ionic pair interactions involving              
at least one occluded charged residue (D398, E406, D442, R454, D467, and R509) is also               
remarkable. 
Table 3. Electrostatic pair interactions between negatively and positively charged          
residues.  
Ionic pair interactions - Distance in Å 
(ASA ratio %) 
E340-K356 
(56% 40%) 
3.6   E406*-R403 
(13% 26%) 





2.8   D420-K424 
(22% 21%) 





5.9   D442*-R509* 
(4% 2%) 





3.1   E465 ​- ​R457 
(36% 21%) 





4.8   E465 ​- ​K462 
(36% 88%) 
5.5       
The N-O distance between basic and acidic groups is shown at the right of each pair.                
The outlined residues correspond to the RBM region, and the other ones to the core.               
The values in brackets correspond to the accessibility of the interacting residues,            
expressed as the percentage of surface exposed. Occluded charged residues (ASA ratio            
<20%) are marked with an asterisk. The index of each residue corresponds to the              
numbering in the Spike protein. For this analysis we used the structure of chain E of the                 
pdb code 6m0j​19​. 
 
The importance of these interactions merits further analysis, as they may           
modulate the conformational dynamics of the RBM, the transitions of the RBD in the              
Spike trimmer, and/or the interaction with the ACE2 receptor.  
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Immune Response elicited by RBD produced in P. pastoris in mice 
With the aim of evaluating the ability of the RBD protein produced in ​P. pastoris               
to stimulate immune response we assessed antibody production in mice by an ELISA             
assay using plates coated with RBD produced either in HEK-293T or in ​P. pastoris​. After               
a first dose of antigen plus adjuvants, mice presented higher antibody titers than             
controls, and after a second dose, the levels of antibodies increased significantly in a              
short period of time (20 days) relative to the first dose ( ​Figure 9A​). No significant               
differences in antibody titers were observed between plates coated with RBD from ​P.             
pastoris or from HEK-293T cells. Thus, immunization of mice with RBD produced in ​P.              
pastoris plus adjuvant induces a high level of specific IgG class antibodies. Next,             
Western blots were performed in which RBD produced either in ​P. pastoris or in              
HEK-293T cells was detected with a serum from mice immunized with RBD produced in              
HEK-293T cells (kindly provided by Dr. Juan Ugalde, University of San Martín, ​Figure 9B,              
left ​), the previously used mouse polyclonal serum from mice immunized with RBD            
produced in ​P. pastoris ​( ​Figure 9B, middle ​), or a primary antibody against the His tag               
present in both RBD recombinant proteins ( ​Figure 9B, right​). Similar bands were            
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Figure 9. Evaluation of the cross-reactivity of antibodies produced in mice           
immunized with ​P. pastoris ​RBD​. ​(A) Titers of antibodies obtained by immunization            
with RBD from ​P. pastoris plus adjuvants. Each bar represents the group mean (n=5) for               
specific titers as determined by end-point-dilution ELISA. ELISA was performed with           
plates coated with RBD protein produced in HEK-293T cells (black sparse bars) or ​P.              
pastoris (red sparse bars). First dose corresponds to blood samples obtained 30 days             
post-first immunization, and second dose to samples obtained 20 days post-second           
immunization. Pre IS, Pre Immune Sera; RBD + Adjuvants, RBD produced in ​P. pastoris +               
Al(OH)​3 + CpG-ODN 1826; Control, Al(OH)​3 + CpG-ODN 1826. P values indicate            
significant differences between different groups. Bars indicate SD. P values (t-test) are            
shown for statistically significant differences (p < 0.05). (B) ​Purified RBD produced in             
HEK-293T (1.0 𝜇g) and in ​P. pastoris (3.0 𝜇g) were analyzed by Western blot using sera                
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from mice immunized with RBD produced in HEK-293T (anti-RBD HEK-293T, left), or in             
P. pastoris ​(anti-RBD, ​P. pastoris ​center). As a control a primary antibody against the              
His tag present in both RBD recombinant proteins was used (right). 
 
Production of RBD by fermentation in bioreactor  
The fermentation of ​P. pastoris in a 7 L stirred-tank bioreactor for the production of               
recombinant RBD ​was carried out using a four-phase procedure described in Methods.            
In the batch phase, cell concentration reached a maximum level of 15.7 g DCW/L after               
18 h of cultivation ( ​Figure 10​). At this stage, ​P. pastoris exhibited a maximum specific               
growth rate ( ​μ ​max​) of 0.21 h ​-1 and a biomass yield coefficient ( ​Y​x/s​) of 0.39 g DCW/g of                 
glycerol. After a spike of dissolved oxygen, the glycerol fed-batch phase was initiated by              
regulating the feeding in response to the level of dissolved oxygen (DO %). Glycerol              
feeding was maintained for 22 h, when biomass concentration reached a value of 60.4              
g DCW/L. After glycerol feeding was stopped, the transition stage was performed by             
feeding with a glycerol (600 g/L):methanol (3:1) mixture for 5 h, to allow a slow cell                
adaptation for the efficient utilization of methanol. At the end of this stage the biomass               
level reached 63.2 g DCW/L. Next, the methanol fed-batch phase was initiated to             
induce recombinant RBD expression, through regulation of pure methanol feeding          
according to DO %. After 48 h of methanol induction and a total fermentation time of                
93 h, the culture reached a biomass concentration of 75.3 g DCW/L, which produced a               
final RBD yield of 45.0 mg/L (>90% pure). Beyond that time point there was no               
significant change in cell concentration and antigen expression level (data not shown).            
At the end of the fermentation, a final volume of 5.5 liters of culture was reached, so                 
that the total amount of RBD obtained was 247.5 mg, the volumetric productivity was              
0.48 mg/L ​ ​h, and the total productivity  2.66 mg/h.  
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Figure 10. ​P. pastoris biomass concentration (g DCW/L) evolution during bioreactor           
fermentation​. P1: batch phase in LSBM glycerol 40 g/L, P2: Fed-batch phase with 600              
g/L glycerol solution, P3: Adaptation phase with glycerol (600 g/L):methanol (3:1)           
mixture, P4: Induction phase with methanol as the sole carbon source. Error bars             
indicate 2SD.  
 
Discussion 
This work materialized the first two goals of our consortium assembled to fight             
COVID-19 pandemia: (a) to express and characterize RBD from SARS-CoV-2, and (b) to             
produce RBD at low cost with high yield. We were able to express this protein in two                 
different systems: ​P. pastoris ​and mammalian cells (HEK-293T), which allowed us to            
gain useful insights concerning RBD conformation and stability.  
We attempted to express RBD in ​E. coli​, even though an examination of its              
structure suggested that this system would not be suited for its expression due to the               
existence of 4 disulfide bonds and a non-globular shape. The ​E. coli SHuffle expression              
system only yielded insoluble RBD (in inclusion bodies) as expected, which was not             
further characterized as it was unsuitable for downstream applications (data not           
shown). In agreement with our results, in a previous attempt to express the similar RBD               
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from SARS-CoV-1 Spike in ​E. coli​, this protein was also found in the insoluble fraction,               
and neither its fusion to thioredoxin, nor to maltose-binding protein, increased its            
solubility. Moreover, while tagging the protein with glutathione ​S​-transferase (GST)          
increased its solubility​34​, it remained strongly bound to the bacterial chaperone GroEL            
even after affinity purification ​35​, thus making it unsuitable for downstream          
applications. 
By contrast, RBD expression in HEK-293T and ​P. pastoris ​eukaryotic cells           
produced soluble and properly folded polypeptides. Their UV-absorption, CD and          
Trp-fluorescence spectra showed high similarity with those previously described for          
SARS-CoV-1 RBD produced in ​P. pastoris​25​. RBD expressed in both eukaryotic systems            
was also characterized by controlled proteolysis and mass spectrometry analysis.          
Remarkably, the peptide of sequence FPNITNLCPFGEVFNATR was not easily detected          
by mass spectrometry. A plausible and straightforward explanation for this result is            
that glycosylation of this peptide at positions N331 (NIT) and N343 (NAT) increases its              
mass, and thus takes the peptide out of the range of mass analysis. The sequence               
coverage corresponding to a similar N-terminal peptide of RBD produced in HEK-293T            
cells was also lower than expected as the peptide VQPTESIVR was not detected, which              
might be due to the presence of ​O ​-glycosylations in this stretch.  
Proteins translocated to the ER are ​N​-glycosylated cotranslationally, and exactly          
the same glycan Glc ​3​Man ​9​GlcNAc​2 is transferred to the N residue in the consensus             
sequence NXS/T (where X cannot be P) of mammalian, plant and yeast proteins. Glc              
residues are immediately removed in the ER, where glycans play a key role in the               
solubility of the glycoproteins and in the so-called “quality control of glycoprotein            
folding” ​36​. Cycles of glucosylation and deglucosylation occur in the endoplasmic          
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reticulum (ER) until the glycoprotein is folded and continues the transit through the             
secretory pathway or, if unable to fold properly, is retrotranslocated to the cytosol and              
degraded by the proteasomes. This mechanism guarantees that only properly folded           
proteins are secreted. Once glycoproteins leave the ER, ​N​-glycans are remodeled in the             
transit through the golgi apparatus and acquire glycan structures that are species            
specific. In yeast ​N ​-glycans in mature proteins are of high mannose type while in              
mammalian proteins are of complex or hybrid type​37​. ​O​-glycosylation of S or T residues              
may also occur in the Golgi, but in this case the monosaccharides are added step by                
step, and are species specific. When RBD purified from ​P. pastoris and HEK-293T cells              
were treated with PNGaseF, which removes both high mannose and complex           
N ​-glycans, a similar band of ∼26 KDa was observed by SDS-PAGE for both proteins, in               
agreement with the expected molecular weight of the proteins lacking ​N​-glycans.           
However, only in the case of RBD obtained from ​P. pastoris the same band was               
observed when proteins were treated with EndoH, which removes high mannose           
glycans, indicating that RBD from ​P. pastoris bears only the expected high mannose             
N ​-glycans, while RBD from HEK-293T likely bears complex or hybrid ones. It has been              
previously reported that SARS-CoV-2 RBD is produced as two predominantly          
N ​-glycosylated forms of∼34 and ∼27 kDa when expressed in Sf9 insect cells​23​. 
Exhaustive removal of ​N​-glycans RBD obtained from HEK-293T cells produced          
two protein forms that migrated as distinct bands, suggesting the presence of either             
two ​O ​-glycosylated isoforms, or of two peptide isoforms. Shajahan and coworkers have            
evaluated the ​O​-glycosylation of SARS-CoV-2 Spike protein produced in HEK-293 cells           
by searching LC-MS/MS data for common ​O​-glycosylation modifications. These authors          
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found ​O​-glycosylation sites at positions T323 and S325, which provides further support            
to our suggestion ​37​.  
For secretory recombinant proteins produced in yeast, high mannose         
hyperglycosylation may be a major issue, as it may potentially alter functional            
properties of the proteins​26​. However, even though RBD expressed in HEK-293T and ​P.             
pastoris exhibited different glycosylation patterns, both conformational and stability         
studies carried out in the present work suggest that both polypeptides have similar             
structures. The stability of both forms was similarly sensitive to changes in ionic             
strength, a result in good agreement with our computational modelling, which predicts            
that a set of ionic interactions stabilizes RBD structure and most likely modulates its              
internal motions. Interestingly, when RBD was unfolded in the absence of reducing            
agents the process was reversible, as judged by the analysis of Trp fluorescence             
spectra, which suggests that Trp residue emission occurs in an apolar and likely more              
rigid environment upon refolding.  
Previously, the thermal stability of a mutated version of RBD from SARS-CoV-1            
Spike named RBD219-N1 (residues 319-536 from Spike, where the first Asn of RBD,             
residue 318, was deleted to avoid glycosylation at the N-terminal region of the protein)              
was analyzed by thermal shift monitoring of extrinsic fluorescence​38​. Remarkably, the           
RBD219-N1 denaturation profile showed an average melting temperature of         
approximately 57 ​o​C, a value significantly higher than that observed for RBD from             
SARS-CoV-2 in this work (approximately 50 ​o​C), which might be due to the fact that               
denaturation of RBD219-N1 was carried out at a considerably lower ionic strength​38​. In             
addition, the pH of the protein sample was not constant throughout the experiment,             
given that the p ​K​a of the Tris buffer used in this work is highly temperature dependent.                
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Alternatively, the suppression of the N-terminal glycosylation in SARS-CoV-1 RBD might           
have an effect on its conformational stability. Nevertheless, the possibility that           
SARS-CoV-1 RBD has particular features that might increase its stability relative to that             
of SARS-CoV-2 RBD should not be excluded. 
In our hands, RBD in its native state was stable under a broad range of pH and                 
concentrations. Although it exhibited a low tendency to aggregate at high           
concentrations, no significant complications were observed during filter-protein        
concentration or dialysis, which was performed either to change the buffer or to             
remove imidazole after protein purification. Freezing (-80 ​o​C) and subsequent thawing           
of RBD did not result in protein aggregation at protein concentrations of 30-40 𝜇M or               
lower, therefore this strategy was used for its storage, as it made unnecessary the use               
of stabilizing molecules such as glycerol or trehalose. However, it should be noted that              
RBD precipitation was occasionally observed after thawing, at protein concentrations          
above 80 𝜇M.  
P. pastoris​-produced RBD was able to stimulate antibody production in mice,           
and the resulting immune sera were capable of detecting RBD produced not only in ​P.               
pastoris but also in HEK-293T cells. Finally, scaling up of RBD expression in ​P. pastoris               
could be performed in a bioreactor with yields greater than 45 mg L ​-1​, which potentially               
allows the large scale immunization of animals in order to produce neutralizing            
antibodies, or the development of SARS-CoV-2 vaccines. Future biotechnological         
developments will be facilitated by the inclusion of a Sortase-A enzyme recognition site             
within the RBD coding sequence, which allows the native covalent coupling of RBD to              
fluorescent probes, peptides, proteins, or modified surfaces, through an efficient          
transpeptidation reaction ​39​. Thus, the Sortase-A-mediated transpeptidation will allow        
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future efficient ​in vitro covalent linking of RBD with protein carriers           
independently-produced in low cost systems such as ​E. coli​.  
 
Methods 
Expression of RBD in mammalian cells  
For RBD expression in mammalian cells, a DNA fragment optimized for           
expression in human cells encoding RBD (Spike residues from 319 to 537, preceded by              
the IL-2 export sequence (MYRMQLLSCIALSLALVTNS) and followed by a C-terminal          
Sortase-A recognition sequence for covalent coupling​39 and a His6 tag for purification            
(LPETGHHHHHH) was synthesized by GenScript (NJ, USA) and cloned into the           
pCDNA3.1(+) plasmid vector (ampicillin R). Expression of RBD was carried out in the             
HEK-293T cell line kindly provided by Xavier Saelens (VIB-University of Ghent, Belgium).            
HEK-293T cells were grown in high glucose (4.5 g L ​-1 glucose) Dulbecco's modified             
Eagle's medium (DMEM, Thermo Fisher Scientific) supplemented with 10% fetal bovine           
serum (FBS, Natocor), penicillin/streptomycin (100 units mL ​-1 and 100 µg mL ​-1           
respectively, Thermo Fisher Scientific) and 110 mg L ​-1 of sodium pyruvate (Thermo            
Fisher Scientific) in a 37°C humidified incubator containing 5% CO ​2​. Cells were plated (2              
x 10​7 cells per 150 mm plate) and grown for 24 h before transfection with               
Polyethylenimine (PEI, Sigma) according to the manufacturer's instructions. Cells were          
grown for 72h before harvesting the culture medium. 
Mammalian cell culture medium was centrifuged twice at 12,0000xg for 20 min            
at 4 ​o​C, later the supernatant pH was adjusted to 8.0 with equilibration buffer (50 mM                
sodium phosphate, 300 mM NaCl and 20 mM imidazole, pH 8,0). RBD was purified              
using a previously equilibrated Ni​2+​-NTA-agarose column. RBD was eluted by increasing           
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concentrations of imidazole prepared in the equilibration buffer. Fractions containing          
the recombinant protein, as judged by the SDS-PAGE analysis, were pooled and            
dialyzed against a buffer without imidazole (20 mM Sodium phosphate, 150 mM NaCl,             
pH= 7,4).  
Expression of RBD in Pichia pastoris 
The RBD coding sequence with codon optimization for ​P. pastoris (Spike amino            
acid residues 319-537) fused to the ​Saccharomyces cerevisiae alpha factor secretion           
signal (N-terminal) ​40 followed by a C-terminal Sortase-A recognition sequence and a           
His6 tag (C-terminal) was synthesized and cloned into pPICZalpha by GenScript (NJ,            
USA) using EcoRI and SacII restriction sites to produce pPICZalphaA-RBD-Hisx6.  
The SacI linearized pPICZalphaA-RBD-Hisx6 vector (10 𝜇g) was used to transform           
electrocompetent X-33 ​P. pastoris strain at 2.5 kV, 25 uF, 200 ohm. Cells recovered in               
ice-cold 1.0 M sorbitol (Sigma) were plated in YPDS (YPD: 1% yeast extract, 2%              
bactopeptone (Difco), 2% glucose, plus 1.0 M sorbitol) supplemented with 100 μg mL ​-1             
zeocin (Invitrogen) and incubated four days at 28 ​o​C. Selected colonies (45) were             
transferred to increasing amounts of zeocin (100 to 500 μg mL ​-1​). The integration at              
AOX site in clones that were resistant to the highest amount of zeocin was confirmed               
by colony PCR using primers AOX​for (5´-GACTGGTTCCAATTGACAAGC-3’) and RBD ​rev (5'          
GTTCCATGCAATGACGCATC 3').  
For RBD production in batch, ​single colonies were used to inoculate BMGY            
medium (1% yeast extract, 2% bactopeptone, 1.34% YNB, 400 μgL​-1 biotin, 0.1 M             
potassium phosphate, pH 6.0, and 1% glycerol) and cultures were grown at 28 ​o​C with               
agitation at 250 rpm until the culture reached a OD ​600nm​= 4-6. Cells were harvested,              
resuspended in either Buffered Methanol-complex Medium (BMMY: 1% yeast extract,          
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(Difco) 2% peptone, 100 mM potassium phosphate pH 6.0, 1.34% YNB, 0.4 mg L ​-1              
biotin, 0.5 % methanol, Sintorgan) or buffered minimal methanol medium containing           
histidine (Sigma) (BMMH: 100 mM potassium phosphate pH 6.0, 1.34% YNB, 0.4 mg L ​-1              
biotin, 4 mg L ​-1 histidine, 0.5 % methanol) to an initial DO ​600nm​= 1.0, and incubated at 28                 
o​C with shaking at 250 rpm in flasks covered with microporous tape sheets for better               
oxygenation. Every 24 hs methanol was added to a final concentration of 0.5% and pH               
was adjusted to 6 if necessary. Induction was maintained during 72-90 h at 28 ​o​C, then                
cells were removed by centrifugation at 3000 ×g for 10 min and the supernatant was               
frozen at -80C until it was used.  
The purification of RBD from culture media was performed using a NTA-Ni​2+            
column previously equilibrated with 50 mM Tris-HCl, 150 mM NaCl, 10% glycerol, pH             
8.0 (equilibration solution). The media supernatants was adjusted to pH 8.0 with NaOH,             
centrifuged 20 min at 12,000 xg and loaded to the column. The flow through was               
reloaded twice. The column was washed with an equilibration solution containing           
20-30 mM imidazole. Finally, RBD was eluted with an equilibration solution containing            
300 mM imidazole. The purified protein was dialyzed twice in 20 mM Tris-HCl, 150 mM               
NaCl buffer, pH 7.4, and quantified by absorbance at 280 nm (see below) and stored at                
-80 ​o​C.  
UV Absorption Spectroscopy 
The concentration of recombinant RBD was determined by UV         
spectrophotometry, using the following extinction coefficients derived from the         
protein sequence (considering all the disulfide bonds formed): for RBD produced in ​P.             
pastoris​: 𝛆​280nm​= 33850 M​–1 cm​–1 (Abs ​280nm​= 1.304 for a 1 mg mL ​-1 protein solution); for                
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RBD produced in HEK-293T cells (without considering IL2 export signal sequence:           
𝛆​280nm​= 33850 M​–1​ cm​–1​ (Abs 280= 1.300 for a 1 mg mL ​-1​ protein solution). 
Absorption spectra (240-340 nm range, using a 0.1-nm sampling interval) were           
acquired at 20 ​o​C with a JASCO V730 BIO spectrophotometer (Japan). Ten spectra for              
each sample were averaged, and blank spectra (averaged) subtracted. A smoothing           
routine was applied to the data by using a Savitzky-Golay filter and subsequently the              
4th derivative spectra were calculated. 
SDS-PAGE and Western Blotting Analysis 
Purified RBD produced in ​P. pastoris or in HEK-293T cells was boiled in sample buffer               
(4% SDS, 20% glycerol, 120 mM Tris, pH 6.8, 0.002% bromophenol blue, 200 mM              
2-mercaptoethanol) and separated in 12% SDS-PAGE. Proteins were either stained with           
Coomassie brilliant blue G-250 or transferred to nitrocellulose membranes (GE          
Healthcare). The membranes were blocked with 5% milk in 0.05% Tween TBS at room              
temperature for 1 h and then incubated at 4 ​o​C overnight with a specific polyclonal               
serum produced by immunization of mice with RBD produced in HEK-293T cells.            
HRP-conjugated anti-mouse were incubated for 1 h at room temperature and           
visualized by enhanced chemiluminescence (ECL, Thermo Scientific).  
Circular Dichroism and Tryptophan Fluorescence 
CD spectra measurements were carried out at 20 ​o​C with a Jasco J-815             
spectropolarimeter. Far-UV and near-UV CD spectra were collected using cells with           
path lengths of 0.1 and 1.0 cm, respectively. Data was acquired at a scan speed of 20                 
nm min​-1 (five scans were averaged, scans corresponding to buffer solution were            
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averaged and subtracted from the spectra). Values of ellipticity were converted to            
molar ellipticity. 
Steady-state tryptophan fluorescence measurements were performed in an        
Aminco-Bowman Series 2 spectrofluorometer equipped with a thermostated cell         
holder connected to a circulating water bath set at 20 ​o​C. A 0.3-cm path length cell was                 
used. The excitation wavelength was set to 295 nm and emission data were collected in               
the range 310–450 nm. The spectral slit-width was set to 3 nm for both              
monochromators. The protein concentration was 3.0-5.0 μM, and the measurements          
were performed in a buffer containing 20 mM sodium phosphate, 150 mM NaCl, pH              
7.40. 
Temperature-Induced Denaturation Monitored by Sypro-Orange     
Temperature-induced denaturation of RBD forms was monitored by the change in the            
Sypro Orange dye (Thermo Fisher) fluorescence using protein at a 5.0 μM            
concentration in 50 mM sodium phosphate buffer, pH 7.0. Samples without protein            
were also included as controls. The dye was used at 2 × (as suggested by Thermo Fisher                 
Scientific). The temperature slope was 1 ​o​C min​-1 (from 20 to 90 ​o​C). Excitation and               
emission ranges were 470–500 and 540–700 nm respectively.  
The fluorescence signal was quenched in the aqueous environment but became           
unquenched when the probe bound to the apolar residues upon unfolding.           
Experiments by triplicate were carried out in a Step One Real-Time-PCR instrument            
(Applied Biosystems, CA, U.S.A.). 
Hydrodynamic Behavior by SEC-HPLC 
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SEC-HPLC was performed using a Superose-6 column (GE Healthcare). The          
protein concentration was 20-30 μM, a volume of 50μL was typically injected, and the              
running buffer was 20 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, pH 7.0. The experiment                
was carried out at room temperature (∼25 ​o​C) at a 0.5 mL min​-1 flow rate. A JASCO HPLC                  
instrument was used. It was equipped with an automatic injector, a quaternary pump             
and a UV-VIS UV-2075 (elution was monitored at 280 nm).  
 
 Production of RBD in P. pastoris by bioreactor fermentation 
P. pastoris was grown on a solid YPD medium containing 20 g L ​-1 peptone, 10 g L ​-1 yeast                  
extract, 20 g L ​-1 glucose and 20 g L ​-1 agar medium at 30 ± 1 ​o​C. As previously described                   
by Chen and coworkers​38​, liquid cultivation was carried out using low salt medium             
(LSM) containing 4.55 g L ​-1 potassium sulfate, 3.73 g L ​-1 magnesium sulfate            
heptahydrate, 1.03 g L ​-1 potassium hydroxide, 0.23 g L ​-1 calcium sulfate anhydrous, 10.9             
mL L ​-1 phosphoric acid 85% and 40 g L ​-1 glycerol, in order to prevent salt precipitation                
during downstream processing due to increased pH. After sterilization, 3.5 mL per liter             
of filtered biotin solution (0.02 % w/v) and 3.5 mL per liter of trace metal solution                
(PTM1) were added. PTM1 contained per liter: 6.0 g copper (II) sulfate pentahydrate,             
0.08 g sodium iodide, 3.0 g manganese sulfate-monohydrate, 0.2 g sodium           
molybdate-dihydrate, 0.02 g boric acid, 0.5 g cobalt chloride, 20.0 g zinc chloride, 65.0              
g ferrous sulfate-heptahydrate, 0.2 g biotin and 5 mL sulfuric acid 5.0 mL.  
Fermentations were conducted in a stirred-tank bioreactor using a four-stage          
process based on Celik ​et al ​. ​26,41​, with slight modifications. The first stage consisted in a               
batch culture using LSM medium with 40 g L ​-1 glycerol as carbon source and              
supplemented with 3.5 mL L ​-1 PTM1 and 3.5 mL L ​-1 biotin solution (0.02 % w/v). Under                
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these conditions yeast cells grew and reached high biomass levels without expression            
of RBD, as it was under the control of ​AOX1 promoter, which is repressed when               
glycerol is provided as an unlimited substrate. In the second phase, a glycerol solution              
(600 g L ​-1 solution supplemented with 12 mL L ​-1 PTM1) was fed into the culture at a                 
growth-limiting rate to increase cell concentration. At the same time, a gradual            
derepression of ​AOX1 promoter takes place under this glycerol-limited condition. This           
phase was initiated after glycerol depletion was evidenced by an oxygen spike. Glycerol             
feeding was automatically regulated according to the percentage of dissolved oxygen           
(DO %) in the culture, with a cut-off of 60 % saturation. Subsequently, a short transition                
stage was conducted by feeding a glycerol:methanol (3:1) mixture, thus allowing the            
adaptation of cells for the growth in the presence of methanol. Finally, the induction              
stage was carried out by adding pure methanol (supplemented with 12 ml L ​-1 ​PTM1) in               
a fed-batch mode with a growth-limiting rate. Methanol feeding was also automatically            
regulated according to the level of DO % in the culture, with a cut-off 50 % saturation. 
In order to obtain the inoculum for bioreactor fermentations, transformed ​P.           
pastoris cells grown on YPD agar plates were inoculated into a 100-mL flask containing              
20 mL of LSM medium with 10 g L ​-1 glycerol (supplemented with PTM1 and biotin) ​and                
cultured overnight at 30 ± 1​o​C. A volume of 300 mL of LSM containing 10 g L ​-1 glycerol                  
(supplemented with PTM1 and biotin) ​in a 1 L Erlenmeyer flask was inoculated with the               
overnight culture and incubated at 30 ± 1°C until the culture reached an OD ​600 of ~16.                
This culture was used to inoculate 3 L of LSM with 40 g L ​-1 glycerol (supplemented with                 
3.5 mL L ​-1 ​PTM1 and 3.5 ml L ​-1 biotin 0.02% w/v) in a 7-L BioFlo 115 bioreactor (New                  
Brunswick Scientific; Edison, NJ), which was interfaced with Biocommand Bioprocessing          
software (New Brunswick Scientific) for parameter control and data acquisition.          
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Temperature was maintained at 30 ± 1°C throughout batch and glycerol fed-batch            
phases and at 25 ± 1°C during transition and induction stages. The pH was maintained               
at 5.0 during the first two phases, and at 5.5 in the last two, by adding H ​3​PO​4 (42.5%)                  
and 14% (v/v) NH​4​OH, which also served as a nitrogen source. DO % was regulated by                
an agitation cascade (maximum of 1200 rpm) and supplemented with filter-sterilized           
(0.22 μm) air and pure oxygen when needed. The pH was measured using a pH               
electrode (Mettler-Toledo GmbH, Germany), and the oxygen concentration was         
measured with a polarographic probe (InPro6110/320, Mettler-Toledo GmbH). Foam         
formation was avoided by the addition of 3 % (v/v) antifoam 289 (Sigma-Aldrich; St.              
Louis, MO). Samples were withdrawn throughout the fermentation process with the           
purpose of evaluating the biomass and recombinant protein expression. 
The optical density of ​P. pastoris culture samples was measured at 600 nm             
using an UV-Vis spectrophotometer and converted to dry cell weights (DCW, in g L ​-1​)              
with a previously calculated DWC versus OD ​600nm ​calibration curve in accordance with            
the formula: DCW= 0.269 x OD ​600nm​ , R​2​= 0.99. 
The protein profile throughout the methanol-induction phase was analyzed by          
12% SDS-PAGE, and gels were stained with Coomassie brilliant blue G-250. RBD            
expression was confirmed by Western blot analysis using anti-RBD and anti-his           
antibodies. Total protein content was estimated by measuring the absorbance at 280            
nm using a Beckman spectrophotometer. 
Glycan removal from RBD 
RBD (5 μg) produced in HEK-293T cells or ​P. pastoris were denatured 10 min at               
100 °C with 0.5% SDS and 40 mM DTT. Then, 1% Nonidet P-40, 50 mM buffer sodium                 
phosphate buffer pH 7.5, and 50 mU of PNGaseF (New England Biolabs) were added to               
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remove complex glycans from RBD produced in HEK-293T cells. High mannose glycans            
of RBD produced in ​P. pastoris were removed by incubation with 5 mU of              
EndoglycosidaseH (Roche) in 50 mM sodium citrate buffer, pH 5.5. Reactions were            
incubated during 1 h at 37 °C and analyzed by SDS-PAGE 12%. Parallel control reactions               
were performed under the same conditions but without adding the endoglycosidase in            
each case. 
Bioinformatic Studies 
A total of 75355 amino acid sequences from Spike protein were downloaded from             
the Global Initiative for Sharing All Influenza Data (GISAID) database          
( ​https://www.gisaid.org ​) ​27​. Multiple sequence alignment was obtained using MAFFT        
v.7453​42​. The RBD region was extracted with the EMBOSS package​43 using the RBD             
region of Uniprot accession ​QHN73795​. Protein identity analysis was performed by           
BLAST using the RBD protein sequence as a query and an e-value of 0.001 was used.                
Sequence identity and coverage percentages were registered and counted. 
Reverse phase HPLC 
For HPLC, a JASCO system equipped with an autoinjector, an oven           
(thermostatized at 25 °C) and a UV detector was used. A gradient from 0 to 100%                
acetonitrile was performed (0.05% TFA (v/v) was added to the solvents). An analytical             
C18 column was used (Higgins Analytical, Inc. U.S.A.), with a 1.0 mL min-1 flow.  
MALDI TOF for intact mass analysis 
The protein samples were analyzed using a MALDI TOF TOF mass spectrometer            
(Applied Biosystems 4800 Plus) operating in linear mode. Previously, the samples were            
desalted on ZipTip C ​4 column (Millipore, Merck KGaA, Darmstadt, Germany), then           
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eluted in a matrix solution of sinapinic acid 10 mg ml ​-1 in 70 % acetonitrile, 0.1 % TFA or                   
2,5 dihydroxy benzoic acid 5 mg ml ​-1 in 70 % acetonitrile, 0.1 % TFA and deposited on                 
the MALDI plate. The spots were allowed to dry and finally the samples were ablated               
using a pulsed Nd:YAG laser (355 nm). Spectra were acquired in positive or negative              
mode, depending on the sample characteristics. 
 ​Tryptic digestion 
The protein samples were digested with trypsin (Promega, mass spectrometry grade) in            
(NH​4​)HCO​3 buffer (0.1 M, pH 8.0), after ON at 37 ​o​C, the cysteine side chains were                
previously modified with DTT-iodoacetamide. The tryptic mixture was desalted using a           
μZipTip μC ​18 column (Millipore, Merck KGaA, Darmstadt, Germany) and were eluted           
with a saturated matrix solution of α cyano-4-hydroxycinnamic acid in          
acetonitrile:water (70:30, 0.1% TFA). Alternatively, the samples were digested in a gel            
following a similar protocol to that used for in solution digestion, with a previous              
washing step. 
MALDI TOF TOF for tryptic peptides analysis 
The spectra were first acquired in reflectron mode and the main signals studied in              
MS/MS mode. The resulting MS/MS spectra were analyzed using the MASCOT search            
engine ​44 (Matrix Science) program and COMET​45 at ​Transproteomic Pipeline. Also, for           
the manual analysis of spectra in reflectron mode, the GPMAW (Lighthouse data)            
program was used. 
Molecular Modelling 
The molecular Modelling analysis of the RBD domain was done using the chain E of the                
pdb structure 6M0J​19​. ​Figures of this structure were done using VMD​46​. The            
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identification of residues making moderate and strong electrostatic interactions within          
RBD was performed using the Salt Bridges plug in of VMD. For the analysis we used a                 
6.0 Å cut-off distance between side chain oxygen and nitrogen atoms of residues D, E, K                
and R. The accessible surface area calculations for the residues of RBD was done using               
the GetArea server ​ ​http://curie.utmb.edu/getarea.html​ using a 1.4 Å probe radius. 
Immunization protocols  
Immunization of mice was carried out by experts from the High Level            
Technological Service CONICET (STAN No. 4482), under ISO9001 guidelines and those           
from the Institutional Committee for the Care and Use of Laboratory Animals (CICUAL).             
BALB/c mice were obtained from the animal facility of the Faculty of Veterinary             
Sciences, University of La Plata (Argentina), and housed at the animal facility of the              
Instituto de Ciencia y Tecnología Dr. César Milstein, Fundación Pablo Cassará. Female            
mice (6-8 week-old) were immunized intraperitoneally with 40 µg RBD protein           
produced in ​P. pastoris ​in the presence of the HPLC-grade phosphorothioate           
oligonucleotide CpG-ODN 1826 (5’ TCCATGACGTTCCTGACGTT 3’) (20 µg/mouse/dose)        
(Oligos etc. Inc., Integrated DNA Technologies, OR, USA) and aluminum hydroxide           
(Al(OH)​3​) (20% (v/v)/mouse/dose) and boosted on day 30 with the same dose.            
Additional control animals were injected with Al(OH)​3 (20% (v/v)) plus CpG-ODN 1826            
(20 µg) per mouse with the same immunization schedule. Pre-immune sera also were             
collected before starting the immunization. Blood samples were obtained at 30 days            
post-first immunization (antigen prime) and 20 days post-second immunization         
(antigen boost) by venipuncture from the facial vein. After coagulation at room            
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temperature for 1-2 h, blood samples were spun in a centrifuge at 3000 rpm/min for 10                
min at 4 °C. The upper serum layer was collected and stored at -20°C. 
Identification of serum antibody against protein RBD in mice using an ELISA assay. 
Standard ELISA procedures were followed to measure antibody response against RBD.           
Briefly, RBD protein produced in ​P. pastoris ​or HEK-293T cells was used to coat              
flat-bottom 96-well plates (Thermo Scientific NUNC-MaxiSorp) at a final concentration          
of 1 µg/ml (100 µl/well) in phosphate-buffered saline (PBS) coating buffer (pH 7.4) at              
4 °C overnight. After blocking with 8% non-fat dry milk PBS for 2h at 37°C the plates                
were washed 5 times with PBS containing 0.05% Tween 20 (PBST). Serially diluted             
mouse sera were incubated at 37 °C for 1.5 h in PBS containing 1% non-fat dry milk                
(blocking solution), and then the plates were washed with PBST. For total specific IgG              
determination, IgG horseradish peroxidase (HRP)-conjugated antibody (DAKO P0447)        
was diluted 1/1000 in blocking solution and added to the wells. After incubation for 1 h                
at 37 °C, plates were washed 5 times with PBST and developed with             
3,3’,5,5’-tetramethylbiphenyldiamine (TMB) for 15 min. The reaction was stopped with          
50 µl/well of 1.0 M H ​2​SO​4 (stop solution). The absorbance was measured in a              
microplate reader (Thermo Multiscan FC ELISA) at 450 nm (A​450​). The antibody titer was              
determined as the inverse of the last dilution that was considered positive, with a              
cut-off value defined as A​450​= 0.20, which was twice as high as that from a pool of                 
Normal mice Sera (from 30 unimmunized animals). Statistical significance was          
evaluated by the Student’s t-test, using a logarithmic transformation of the ELISA titers.             
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